Form 4 for MANE Veradermics, Inc

Accepted 2026-09-03 16:35:03 ET · period of report 2026-09-01 · accession 0001628280-26-060491 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-09-03 16:35	2026-09-01	MANE	Hollander David	Chief R, D Off	A - Grant	$0.00	+9,650	9,650	New	$0
D	2026-09-03 16:35	2026-09-01	MANE	Hollander David	Chief R, D Off	A - Grant	$0.00	+19.3K	19.3K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-09-01	A	A	9,650	$0.00	9,650	D	—	—	(F1) These shares represent restricted stock units (RSUs) granted under the Veradermics, Incorporated 2026 Incentive Plan. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on each anniversary of the grant date (September 1, 2027, September 1, 2028, September 1, 2029, and September 1, 2030), subject to continued service.
2	Derivative	Stock Option (Right to Buy)	2026-09-01	A	A	19,300	$0.00	19,300	D	$97.51 · — to 2036-09-01	19,300 Common Stock	(F2) The option vests as to 25% of the underlying shares of Common Stock on September 1, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.